10 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
algorithms by Global ... Chronic Obstructive Lung ... Disease grade. ... LAMA: long-acting ... #Management #Pulmonary
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... Disease Initial ... disease (COPD) ... #Algorithm #Management ... #Pulmonary #LABA
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis infections/year ... Tuberculosis Diagnosis ... Tuberculosis Treatment ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis infections/year ... Tuberculosis Diagnosis ... Tuberculosis Treatment ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
Syphilis - Clinical Manifestations and Treatment

1) Primary Syphilis
 • Direct lesion contact during sex is responsible
meningovascular disease ... ulcerated • MSK ... Coronary artery disease ... Syphilis #stages #diagnosis ... #management #Treatment
Paget's Disease of Bone

 • Characterized by an ↑ rate of bone turnover with both excessive
appearance on x-ray ... the effects of a latent ... bodies, pelvis, and long ... #Bone #diagnosis ... #management #treatment
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
life-threatening diseases ... Inflammatory eye disease ... Labs: • BMP (quantify ... sparing of the lung ... #management #treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... phenomenon (16%) MSK ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... #Management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Determine if any labs ... unless prior heart/lung ... medical and surgical management ... stratification #diagnosis
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
: • Labs nonspecific ... extrapulmonary disease ... change in the lungs ... nails, bronchi, lungs ... #Management #Infections